| Technology Name | Briefcase | Lead Researcher |
|---|---|---|
COVID-19
Pepticom is implementing its proprietary core AI technology on various Coronavirus proteins and the ACE2 to identify novel inhibitors that can fight Sars Cov2. They are currently looking for partners to validate and develop these ... More | Goldblum Amiram | |
Background
Most active pharmaceutical ingredients (APIs) are not suitable for “passive” loading into nano-liposomes. The desired concentration in the nano-liposomes is hard to achieve. Consequently, the therapeutic efficacy in humans is not ... More | Goldblum Amiram | |
Background
Toll-like receptors (TLRs) have been implicated in several autoimmune and inflammatory diseases, including cancer, diabetes, cardiovascular disease, atherosclerosis, Alzheimer’s disease, and chronic neuropathic pain.
Currently, ... More | Goldblum Amiram | |
Categories
Drug delivery, Infectious disease
Development Stage
Pre-clinical efficacy studies
Patent Status
Patent pending
Market
The invention is related to the field of antibiotic resistant bacteria (N. gonorrhoeae, MRSA, Streptococcus ... More | Barenholz Yechezkel | |
Categories:
Life sciences and Biotechnology
Technology Keywords:
Drug Development, PPARD, Obesity, Glycogen Preserving, Lipid Metabolism, Wound Healing
Development Stage:
In silico, Identification of lead molecules, in vitro ... More | Goldblum Amiram |